Abstract
Selective activation of cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase type I (cAKI), but not type II, is sufficient to mediate inhibition of T cell replication induced through the antigen-specific T cell receptor-CD3 (TCR-CD3) complex. Immunocytochemistry and immunoprecipitation studies of the molecular mechanism by which cAKI inhibits TCR-CD3-dependent T cell replication demonstrated that regulatory subunit I alpha, along with its associated kinase activity, translocated to and interacted with the TCR-CD3 complex during T cell activation and capping. Regulatory subunit II alpha did not. When stimulated by cAMP, the cAKI localized to the TCR-CD3 complex may release kinase activity that, through phosphorylation, might uncouple the TCR-CD3 complex from intracellular signaling systems.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Carrier Proteins / analysis
-
Carrier Proteins / metabolism*
-
Cyclic AMP / metabolism
-
Cyclic AMP-Dependent Protein Kinase Type II
-
Cyclic AMP-Dependent Protein Kinases / analysis
-
Cyclic AMP-Dependent Protein Kinases / metabolism*
-
Enzyme Activation
-
Fluorescent Antibody Technique
-
Humans
-
Immunologic Capping
-
Intracellular Signaling Peptides and Proteins*
-
Lymphocyte Activation
-
Phosphorylation
-
Precipitin Tests
-
Receptor-CD3 Complex, Antigen, T-Cell / analysis
-
Receptor-CD3 Complex, Antigen, T-Cell / metabolism*
-
Signal Transduction
-
T-Lymphocytes / enzymology*
-
T-Lymphocytes / immunology
Substances
-
Carrier Proteins
-
Intracellular Signaling Peptides and Proteins
-
Receptor-CD3 Complex, Antigen, T-Cell
-
protein kinase modulator
-
Cyclic AMP
-
Cyclic AMP-Dependent Protein Kinase Type II
-
Cyclic AMP-Dependent Protein Kinases